Idiopathic pulmonary fibrosis is a progressive and life-threatening lung disease but there are ASX companies bringing hope to ...

Noble Capital initiated coverage of Gyre Therapeutics (GYRE) with an Outperform rating. Gyre is developing drugs for inflammatory diseases that ...

Scientists at the University of Virginia have discovered that as men age, they often lose the Y chromosome in some of their ...

A challenging treatment landscape Although drugs such as Roche’s Esbriet (pirfenidone) and Boehringer Ingelheim’s Ofev (nintedanib) are licensed in major markets, they can only slow ...

First worldwide surgical procedure of giant inguinoscrotal repair with the new Hugo robotic assisted system: video and docking presentation (3 March, 2025) ...